China (Mainland)
Assessedsupplier 
Metoprolol tartrate CAS NO.56392-17-7
- Min.Order: 1 Kilogram
- Payment Terms: L/C,T/T,MoneyGram,Other
- Product Details
Keywords
- Metoprolol tartrate price
- Metoprolol tartrate CAS 5692-17-7
- Metoprolol tartrate supplier in China
Quick Details
- ProName: Metoprolol tartrate
- CasNo: 56392-17-7
- Molecular Formula: 2C15H25NO3.C4H6O6
- Appearance: crystalline powder
- Application: A β1 selective aryloxypropanolamine an...
- DeliveryTime: 15 days after order confirmed
- PackAge: 1kg/bag, 1kg/drum or 25kg/drum or as p...
- Port: Shanghai, Ningbo, Tianjin, etc
- ProductionCapacity: 500 Kilogram/Month
- Purity: 99%
- Storage: Stored in cool, dry and ventilation pl...
- Transportation: by courier door to door or by sea
- LimitNum: 1 Kilogram
Superiority
Superior quality, moderate price & quick delivery.
Details
| Metoprolol tartrate Chemical Properties |
| storage temp. | Desiccate at RT |
| Stability: | Stable. Incompatible with strong oxidizing agents. |
| CAS DataBase Reference | 56392-17-7(CAS DataBase Reference) |
| Safety Information |
| RTECS | UB7450100 |
| MSDS Information |
| Provider | Language |
|---|---|
| 1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol (2:1) Dextro-tartrate salt | English |
| Metoprolol tartrate Usage And Synthesis |
| Chemical Properties | Crystalline Powder |
| Usage | A ? selective aryloxypropanolamine andrenergic antagonist. Used in the treatment of a variety of cardiovascular disorder. Antihypertensive; antianginal; antiarrhythmic (class II) |
| Usage | A β1 selective aryloxypropanolamine andrenergic antagonist. Used in the treatment of a variety of cardiovascular disorder. Antihypertensive; antianginal; antiarrhythmic (class II). |
| Usage | alpha(1)-adrenergic blocker |
| Biological Activity | Selective β 1 -adrenoceptor antagonist (K i values are 47, 2960 and 10100 nM for β 1 , β 2 and β 3 adrenoceptors respectively). Inhibits spontaneous endothelin-1 production in vitro and displays antihypertensive and antianginal activity in vivo . |